{
    "Trade/Device Name(s)": [
        "AssureTech Buprenorphine Strip",
        "AssureTech Methadone Strip",
        "AssureTech Buprenorphine/Methadone Panel Dip",
        "AssureTech Buprenorphine/Methadone Quick Cup",
        "AssureTech Buprenorphine/Methadone Turn Key-Split Cup"
    ],
    "Submitter Information": "Assure Tech. Co., Ltd.",
    "510(k) Number": "K152025",
    "Predicate Device Reference 510(k) Number(s)": [
        "K142396"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJR",
        "DJG"
    ],
    "Summary Letter Date": "July 17, 2015",
    "Summary Letter Received Date": "July 22, 2015",
    "Submission Date": "September 17, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.3620",
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Methadone test system",
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Buprenorphine",
        "Methadone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow system"
    ],
    "Methodologies": [
        "Competitive binding immunoassay",
        "Lateral flow immunochromatography"
    ],
    "Submission Type(s)": [
        "Strip",
        "Panel Dip",
        "Quick Cup",
        "Turn Key-Split Cup"
    ],
    "Document Summary": "FDA 510(k) summary for AssureTech Buprenorphine and Methadone tests for qualitative detection of buprenorphine and methadone in human urine using immunochromatographic lateral flow assays.",
    "Indications for Use Summary": "Qualitative determination of buprenorphine and/or methadone in human urine at specified cutoff concentrations, intended for over-the-counter and prescription use as preliminary screening with confirmatory testing required.",
    "fda_folder": "Toxicology"
}